TIMELY-PrädiktoR Prospective Study
Brief Summary: Cardiac rehabilitation (CR) is a multi-factorial intervention, designed to limit the physiological and psychological effects of cardiovascular disease such as coronary artery disease (CAD), manage symptoms, and reduce the risk of future cardiovascular events. CR is a structured program not only addressin
| Condition(s) | Coronary Artery Disease |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Brief Summary: Cardiac rehabilitation (CR) is a multi-factorial intervention, designed to limit the physiological and psychological effects of cardiovascular disease such as coronary artery disease (CAD), manage symptoms, and reduce the risk of future cardiovascular events. CR is a structured program not only addressing CAD but also comorbidities including hypertension, dyslipidemia, diabetes and obesity as well as other risk factors. CR aims at long-term lifestyle changes to reduce modifiable risk factors, and it's success depends on a large number of interacting variables including biological, psychological and social factors. Recently, the importance of patient-centered approaches to secondary prevention and CR success has been underlined but intra-individual factors and their interacti |
| Who can participate | Inclusion Criteria: Coronary Artery Disease (CAD) patients after myocardial infarction (STEMI/NSTEMI) and/or angioplasty and/or Percutaneous Coronary Intervention (PCI) and/or coronary artery bypass graft surgery who participate in phase II Cardiac Rehabilitation (CR). Exclusion Criteria: * Incapability to give informed consent * Conditions that prevent patients from participation in CR including unstable coronary or cerebrovascular conditions and acute infections |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Dr. Boris Schmitz |
| Locations | Ennepetal, North Rhine-Westphalia, Germany |
| Start date | 2021-06-01 |
| NCT ID | NCT05461729 |
| Official listing | https://clinicaltrials.gov/study/NCT05461729 |